Lilly launches new "Brain Health Matters" campaign in partnership with Julianne Moore, empowering the public to prioritize brain health
Eli Lilly (NYSE:LLY) has launched "Brain Health Matters," a global campaign aimed at promoting proactive brain health and early detection of Alzheimer's disease. The company has partnered with acclaimed actress Julianne Moore to raise awareness, particularly among women who represent nearly two-thirds of Alzheimer's diagnoses.
The multi-year campaign builds on 35 years of brain health research and comes as statistics show that 13.8 million people aged 65 and older are projected to have Alzheimer's dementia by 2060. The initiative emphasizes early intervention, noting that Alzheimer's can begin up to 20 years before symptoms appear. The campaign will run across U.S. television, digital, and audio platforms, with plans for global expansion.
Eli Lilly (NYSE:LLY) ha lanciato "Brain Health Matters", una campagna globale che promuove la cura proattiva del cervello e la diagnosi precoce del morbo di Alzheimer. L'azienda ha coinvolto l'acclamata attrice Julianne Moore per sensibilizzare in particolare le donne, che rappresentano quasi due terzi delle diagnosi di Alzheimer.
La campagna, della durata pluriennale, si basa su 35 anni di ricerca sulla salute cerebrale e arriva mentre le proiezioni indicano che saranno 13,8 milioni le persone di età pari o superiore a 65 anni con demenza di Alzheimer entro il 2060. L'iniziativa sottolinea l'importanza dell'intervento precoce, ricordando che l'Alzheimer può iniziare fino a 20 anni prima della comparsa dei sintomi. La campagna andrà in onda su televisione, piattaforme digitali e audio negli Stati Uniti, con piani di espansione globale.
Eli Lilly (NYSE:LLY) ha lanzado "Brain Health Matters", una campaña global orientada a fomentar el cuidado proactivo del cerebro y la detección temprana de la enfermedad de Alzheimer. La compañía se ha asociado con la reconocida actriz Julianne Moore para aumentar la concienciación, especialmente entre las mujeres, que representan casi dos tercios de los diagnósticos de Alzheimer.
La campaña plurianual se apoya en 35 años de investigación sobre la salud cerebral y llega en un momento en que las estadísticas proyectan que serán 13,8 millones las personas de 65 años o más con demencia por Alzheimer para 2060. La iniciativa destaca la intervención temprana, señalando que el Alzheimer puede comenzar hasta 20 años antes de que aparezcan los síntomas. La campaña se difundirá en televisión, plataformas digitales y audio en EE. UU., con planes de expansión global.
Eli Lilly (NYSE:LLY)는 "Brain Health Matters"라는 글로벌 캠페인을 시작했습니다. 이 캠페인은 적극적인 두뇌 건강 관리와 알츠하이머병의 조기 발견을 장려하는 것을 목표로 합니다. 회사는 특히 알츠하이머 진단의 거의 2/3를 차지하는 여성들에게 인식을 높이기 위해 유명 배우 줄리안 무어 (Julianne Moore)와 협력했습니다.
이 다년간 캠페인은 35년간의 뇌 건강 연구를 바탕으로 하며, 통계에 따르면 2060년까지 65세 이상 인구 중 1,380만 명이 알츠하이머성 치매를 겪을 것으로 예상된다는 사실과 함께 추진됩니다. 이 이니셔티브는 알츠하이머가 증상 발현 최대 20년 전에 시작될 수 있음을 지적하며 조기 개입의 중요성을 강조합니다. 캠페인은 미국의 텔레비전, 디지털 및 오디오 플랫폼에서 전개되며 전 세계 확대를 계획하고 있습니다.
Eli Lilly (NYSE:LLY) a lancé "Brain Health Matters", une campagne mondiale visant à promouvoir la santé cérébrale proactive et la détection précoce de la maladie d'Alzheimer. L'entreprise s'est associée à la célèbre actrice Julianne Moore pour sensibiliser, en particulier les femmes qui représentent près des deux tiers des diagnostics d'Alzheimer.
La campagne pluriannuelle s'appuie sur 35 ans de recherche sur la santé du cerveau et intervient alors que les statistiques prévoient que 13,8 millions de personnes âgées de 65 ans et plus pourraient être atteintes de démence due à Alzheimer d'ici 2060. L'initiative met l'accent sur l'intervention précoce, rappelant que la maladie d'Alzheimer peut commencer jusqu'à 20 ans avant l'apparition des symptômes. La campagne sera diffusée à la télévision, sur des plateformes numériques et audio aux États-Unis, avec des plans d'expansion mondiale.
Eli Lilly (NYSE:LLY) hat "Brain Health Matters" gestartet, eine globale Kampagne zur Förderung proaktiver Gehirngesundheit und zur frühzeitigen Erkennung der Alzheimer-Krankheit. Das Unternehmen arbeitet mit der bekannten Schauspielerin Julianne Moore zusammen, um vor allem Frauen anzusprechen, die nahezu zwei Drittel der Alzheimer-Diagnosen ausmachen.
Die mehrjährige Kampagne baut auf 35 Jahren Forschung zur Gehirngesundheit auf und erscheint vor dem Hintergrund, dass bis 2060 voraussichtlich 13,8 Millionen Menschen im Alter von 65 Jahren und älter an Alzheimer-Demenz leiden werden. Die Initiative betont frühes Eingreifen und weist darauf hin, dass Alzheimer bis zu 20 Jahre vor Auftreten von Symptomen beginnen kann. Die Kampagne läuft in den USA über Fernsehen, digitale und Audio-Plattformen, mit Plänen zur globalen Ausweitung.
- Partnership with high-profile actress Julianne Moore increases campaign visibility and credibility
- Campaign targets women who represent two-thirds of Alzheimer's diagnoses, addressing a key demographic
- Multi-channel approach across TV, digital, and audio platforms maximizes reach
- Planned global expansion indicates potential for broader market impact
- None.
Acclaimed actress, author, and advocate Julianne Moore joins cause in
Nearly four in five Americans say they would want to know if they have Alzheimer's disease before symptoms interfere with daily activities, highlighting the growing desire for open conversations and early detection1
With the number of people aged 65 and older with Alzheimer's dementia projected to reach 13.8 million by 20601 and rapid advances in science, early action to support brain health is more important than ever
To raise campaign awareness and motivate action—particularly among women, who account for almost two-thirds of Alzheimer's disease diagnoses— actress, author, and advocate Julianne Moore has partnered with Lilly in
"As our population ages and we see the positive impact of earlier intervention in symptomatic Alzheimer's disease, it is becoming critical that we assess brain health regularly. This campaign is about getting more people to talk about brain health and prioritize it along with other aspects of routine healthcare. By having early and regular conversations with each other and our health care providers, we can take real steps to stay ahead of Alzheimer's disease and reduce the stigma around this disease," said Anne E. White, executive vice president and president of Lilly Neuroscience. "We're honored to partner with Julianne Moore to help people understand why brain health should be on their priority list."
Why early action matters
Alzheimer's disease can begin as early as 20 years before symptoms appear, when amyloid—a protein the body produces naturally—abnormally accumulates in the brain as plaques. Individuals can take proactive steps with their doctor to support brain health—including understanding risk factors and which of those may be modifiable through lifestyle changes.1-3 For people with Alzheimer's disease, research indicates that earlier detection and accurate diagnosis contribute to better care for patients.
"Brain health is something we don't talk about often enough," said Julianne Moore. "One of the things that has stayed with me from my conversations with people living with Alzheimer's disease is that taking responsibility for one's brain health is essential for protecting our freedom to do the things that make life meaningful. I've seen how much proactive care matters in helping us keep doing what we love. That's why I'm encouraging everyone to prioritize their brain health through regular conversations with their doctors."
Making brain health a priority
Launched during World Alzheimer's Month, Brain Health Matters empowers people to take charge of their brain health with new tools and resources on how people can:
- Ask their doctor about risk factors for dementia due to Alzheimer's disease and cognitive assessments at their appointment; and,
- Start building their personal cognitive health plan by discovering everyday habits that help support their brains.
The Brain Health Matters campaign is designed to reach audiences through the platforms they use most, with the campaign running on
To learn more about risk factors for dementia from conditions like Alzheimer's disease and why it may be time for a cognitive assessment, visit BrainHealthMatters.com.
PP-AD-US-0884 09/2025
© Lilly
About Lilly
Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news, or follow us on Facebook, Instagram, and LinkedIn. C-LLY
References:
- Alzheimer's Association. 2025 Alzheimer's disease facts and figures. Alzheimers Dement. 2025;21(5):3708-3821. doi:10.1002/alz.70235
- Porsteinsson AP, Isaacson RS, Knox S, et al. Diagnosis of early Alzheimer's disease: clinical practice in 2021. J Prev Alzheimers Dis. 2021;8:371-386. doi:10.14283/jpad.2021.23
- Livingston G, Huntley J, Liu KY, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet. 2024;404:572-628.
Refer to: | Michael Carson; michael.carson@lilly.com; 872-350-2138 (Media) |
Michael Czapar; czapar_michael_c@lilly.com; 317-617-0983 (Investors) |
View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-launches-new-brain-health-matters-campaign-in-partnership-with-julianne-moore-empowering-the-public-to-prioritize-brain-health-302549759.html
SOURCE Eli Lilly and Company
FAQ
What is Eli Lilly's Brain Health Matters campaign about?
Why did Eli Lilly partner with Julianne Moore for the Brain Health Matters campaign?
When does Alzheimer's disease begin according to Lilly's campaign?
How many Americans with Alzheimer's are projected by 2060?
Where can people learn more about Eli Lilly's Brain Health Matters campaign?
